Health Canada okays cardiac deviceZargis Cardioscan wireless device approved for sale Multiple myeloma patients’ prospects improving: studyNew drugs are prolonging survival in high- and low-risk cases Pharmacy’s role in H1N1: Newfoundland and Labrador Preparing to Launch: Drugs in late-stage development A look at drugs in the late stages of development in Canada The Pharmacists’ NHP Symposium: Update on NHP regulation in Canada New antibiotic, type 2 diabetes drugs hit market Who was naughty? Who was nice? Medical Post staffers give the year a review, with jeers and cheers for 2009’s newsmakers Opioid- and oxycodone-related deaths rise in Ontario CMAJ study shows substantial increase in mortality Micardis: now indicated for CV event reduction Heparin: new USP standards will reduce potency of some products First Previous 244 245 246 247 248 Next Last
